These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 480717)

  • 1. [The role of renal pressor and depressor substances (author's transl)].
    Abe K
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):408-12. PubMed ID: 480717
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal prostaglandin E in renoparenchymal hypertension.
    Hsieh BS; Chen WY; Yen TS; Hsu HC
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):627-33. PubMed ID: 6389755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on renal prostaglandin E in essential hypertension: relationships among urinary prostaglandin E, sodium balance, renin-angiotensin-aldosterone system and renal kallikrein-kinin system (author's transl)].
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Seino M; Sakurai Y; Saito K; Kusaka T; Imai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1537-45. PubMed ID: 744897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renin-aldosterone system in patients with hypertensive form of chronic glomerulonephritis and preserved renal function].
    Borovkova NIu; Borovkov NN; Sidnev BN
    Klin Med (Mosk); 2009; 87(8):61-3. PubMed ID: 19827534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of urinary kallikrein in patients with various types of hypertension (relationship to renin-angiotension-aldosterone system (author's transl)].
    Seino M
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):877-87. PubMed ID: 713164
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term treatment with captopril in hypertension due to acute glomerulonephritis.
    Parra G; Rodríguez-Iturbe B; Colina-Chourio J; García R
    Clin Nephrol; 1988 Feb; 29(2):58-62. PubMed ID: 3282729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension.
    Bras H; Ochs HG; Armbruster H; Heintz R
    Clin Nephrol; 1976 Feb; 5(2):57-60. PubMed ID: 943254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
    Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamines, sodium and renin in unilateral renal hypertension in man.
    Weidmann P; Schiffl H; Ziegler WH; Glück Z; Meier A; Keusch G
    Miner Electrolyte Metab; 1982 Feb; 7(2):97-112. PubMed ID: 6763143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)].
    Nakamura Y
    Nihon Naika Gakkai Zasshi; 1980 Jun; 69(6):714-22. PubMed ID: 6997417
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of renal hypertension (author's transl)].
    Cottier P
    Radiologe; 1975 Apr; 15(4):130-8. PubMed ID: 1101291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary prostaglandin E in patients with hypertension--relationship to renin-angiotensin-aldosterone system (author's transl)].
    Chiba S; Abe K; Yasujima M; Sato M; Ito T; Sakurai Y; Haruyama T; Irokawa N; Otsuka Y; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):739-51. PubMed ID: 7009938
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis].
    Riabov SI; Kucher AG; Kotovoĭ IuO; Kaiukov IG
    Klin Med (Mosk); 1990 Dec; 68(12):22-5. PubMed ID: 2084330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Baroflex sensitivity in endstage chronic glomerulonephritis (author's transl)].
    Tomiyama O
    Nihon Jinzo Gakkai Shi; 1979 Jun; 21(6):609-22. PubMed ID: 491307
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kidney and hypertension (author's transl)].
    Truniger B
    Schweiz Rundsch Med Prax; 1974 May; 63(19):579-83. PubMed ID: 4364216
    [No Abstract]   [Full Text] [Related]  

  • 18. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renin-aldosterone behavior in hypertensive chronic glomerulonephritis].
    Brass H; Ochs HG; Armbruster H; Heintz R
    Verh Dtsch Ges Inn Med; 1975; 81():1023-6. PubMed ID: 1229391
    [No Abstract]   [Full Text] [Related]  

  • 20. [The renin-angiotensin-aldosterone system in hypertensive subjects. III- The use of beta-blockers in reno-vascular hypertension (author's transl)].
    Lardoux H; Vial FS; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1977 Sep; 6(30):2659-63. PubMed ID: 20602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.